Monoamine oxidase inhibitors (MAOI) increase rat brain aromatic amino acid decarboxylase activity.
D000818:Animals; D001142:Aromatic-L-Amino-Acid Decarboxylases / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010624:Phenelzine / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors; D014191:Tranylcypromine / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D001142:Aromatic-L-Amino-Acid Decarboxylases; D010624:Phenelzine